Milestone Scientific Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
34.1%projected annual EPS growth
Analyst Coverage
2analysts covering
FY Revenue (est.)
$10Mnext fiscal year
FY EPS (est.)
-$0.04next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 13 Nov 2026 |
| FY 2026 Earnings Release | 31 Mar 2027 |
Monitoring Framework
Key Performance Indicators
Total Revenue Annually9MTarget: 9800000 to 10200000
CompuFlo Segment Revenue Annually110KTarget: 500000 to 600000
Gross Margin Quarterly7,230.0%Target: Maintain robust margins above 70%
Watch Items
- NYSE American Continued Listing ComplianceTrigger: Stockholders' equity below $4.0 million and $6.0 million thresholdsAction: Regain compliance by the April 8, 2027 deadline to avoid potential delisting.
- Going Concern UncertaintyTrigger: Substantial doubt about ability to continue as a going concern due to recurring operating losses and accumulated deficitAction: Execute on commercial expansion, maintain strict cost discipline, and leverage the April 2026 capital raise to extend runway.
- CompuFlo Advisor Program and ReimbursementTrigger: Targeting 1,000 to 2,000 case submissions in select MAC jurisdictionsAction: Support physician partners with dedicated reimbursement infrastructure to transition CPT code 0777T from Category III to Category I.
Research as of 20 Jun 2026